title: [Long-term therapy of bronchial asthma with ingacort].
abstract: 68 patients with bronchial asthma (BA) were followed up for 2 years. 11 of them suffered from BA stage III (group 1), 27 patients had BA stage IV (group 2). All the patients were administered ingacort as a basic medicine in daily dose 1000-2000 micrograms/day. Before ingacort treatment, patients of group 2 received prednisolone in daily dose 5-40 mg for 2-20 years. As a result of the treatment with ingacort group 1 and group 2 patients improved to stage II and III, respectively. The cost of the treatment was reduced 3.6-fold.
authors.forename: I V
authors.initials: IV
authors.lastname: Leshchenko
authors.forename: E I
authors.initials: EI
authors.lastname: Kuznetsova
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009330:Nebulizers and Vaporizers; D011239:Prednisolone / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D012129:Respiratory Function Tests
chemical_list: D000336:Aerosols; D001993:Bronchodilator Agents; D004338:Drug Combinations; D005938:Glucocorticoids; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D011239:Prednisolone; D009241:Ipratropium
vernacular_title: Resul'taty dlitel'nogo lecheniia ingakortom bol'nykh bronkhial'noĭ astmoĭ.